US Patent 11179434 Lisinopril formulations
Patent 11179434 was granted and assigned to Silvergate Pharmaceuticals, Inc. on November, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11179434 Lisinopril formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
